AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma
Shape Therapeutics, Inc. Raises $35.5M Series A Financing, Led by NEA and Announces the Formation of a World-Class Scientific Advisory Board, to Advance a First-in-Class RNA Editing Gene Therapy Platform Focused on Curing Genetic Diseases
TetraScience secures investment from Waters Corporation, joining Floodgate Capital, First Round, Underscore VC, Founder Collective and Y Combinator in $8M series A
